/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Fabio Grunspun Pitta graduated in Medicine from the University of São Paulo and completed his specialization in Cardiology at Heart Institute of the University of São Paulo ( InCor). He is finishing PHD at the Faculty of Medicine of the University of São Paulo - FMUSP in the Department of Cardiopneumology at University of São Paulo. He is also a physician in the Atherosclerosis Clinical Unit of the Heart Institute and at the Albert Einstein Israeli Hospital in São Paulo (HIAE).
Empagliflozin for prevention of acute kidney injury in patients with type 2 diabetes mellitus undergoing extracorporeal on-pump CABG: The POST-CABGDM trial
Event: ESC Congress 2024
Topic: Revascularisation
Session: Smaller trials and trial updates on shock, surgery, and other interventions
